IDO1 and neoplasm: The role of IDO1 in tumour-induced tolerance was first described by Uyttenhove et al (2003) in a murine model, in which they showed that IDO1 expression in cancer cells protects tumours from attack by tumour-associated antigen-specific host cytotoxic T cells.